High Flow Nasal Cannula in Comparison With Nasal Continuous Positive Airway Pressure in the Management of Respiratory Distress Syndrome
Completed · Not applicable
Conditions studied: Respiratory Distress Syndrome
In brief
To compare the primary outcome, failure of extubation defined by the need for re-intubation and mechanical ventilation within 5 days of initial extubation and secondary outcomes, morbidities and mortality after using of heated humidity high flow nasal cannula (HHHFNC) and Nasal Continuous Positive Airway Pressure (NCPAP) in the immediate post-extubation period for preterm infants between 24 and 28 weeks gestation with respiratory distress syndrome.
Key facts
- Study ID
- NCT02587832
- Run by
- Sidra Medicine
- People needed
- 60
- Starts
- 2009-07-01
- Expected to finish
- 2012-04-01
- Last updated by the study team
- 2015-10-27
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Preterm neonates with gestational age of 24 to 28 completed weeks.
- In the case of twins, both neonates were included in the same treatment arm.
- Success to wean with 24 hours to extubate.
- Parental written informed consent for participation in the study obtained on admission into the hospital or prior to delivery.
You may not qualify if…
- Evidence of severe birth asphyxia.
- Known genetic or chromosomal disorders.
- Infants delivered to mothers with ruptured membranes of more than three weeks duration.
- Potentially life-threatening conditions unrelated to prematurity.
- Participation in another clinical trial of any placebo, drug, biological, or device conducted under the provisions of a protocol.
Where it is running
- Akron Children's Hospital — Akron, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.